IPILIMUMAB AND BEVACIZUMAB IN GLIOBLASTOMA

被引：0
|
作者：
Mulholland, Paul [1 ,2 ]
Shaw, Heather [3 ]
机构：
[1] Univ Coll London Hosp, London, England
[2] Univ Coll London Hosp, Private Brain Unit, London, England
[3] Mt Vernon Canc Ctr, London, England
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou265.22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NT-24
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Ipilimumab and Bevacizumab in Glioblastoma
    Carter, T.
    Shawy, H.
    Cohn-Brown, D.
    Chester, K.
    Mulholland, P.
    CLINICAL ONCOLOGY, 2016, 28 (10) : 622 - 626
  • [2] Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective?
    Tini, P.
    Pirtoli, L.
    CLINICAL ONCOLOGY, 2016, 28 (10) : 663 - 663
  • [3] SURVIVAL AND EFFICACY DATA FOR PATIENTS WITH GLIOBLASTOMA TREATED WITH IPILIMUMAB IN COMBINATION WITH BEVACIZUMAB
    Carter, Thomas
    Brown, Nicholas
    Shaw, Heather
    Chester, Kerry
    Cohn-Brown, Denise
    Mulholland, Paul
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [4] CLINICAL OUTCOMES WITH IPILIMUMAB IN COMBINATION WITH BEVACIZUMAB IN PATIENTS WITH RECENTLY DIAGNOSED GLIOBLASTOMA - A RETROSPECTIVE COHORT REVIEW
    Brown, Nicholas
    Carter, Thomas
    Cohn-Brown, Denise
    Mulholland, Paul
    NEURO-ONCOLOGY, 2017, 19 : 30 - 30
  • [5] Bevacizumab for glioblastoma
    Narita, Yoshitaka
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1759 - 1765
  • [6] IPILIMUMAB FOR RECURRENT GLIOBLASTOMA (GBM)
    Schaff, Lauren R.
    Lassman, Andrew B.
    Goldlust, Samuel A.
    Cloughesy, Timothy
    Singer, Samuel
    Schwartz, Gary K.
    Iwamoto, Fabio M.
    NEURO-ONCOLOGY, 2014, 16
  • [7] Ipilimumab: an investigational immunotherapy for glioblastoma
    Youssef, Gilbert
    Dietrich, Jorg
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (11) : 1187 - 1193
  • [8] Bevacizumab and ipilimumab/nivolumabHepatotoxicity: case report
    Reactions Weekly, 2018, 1687 (1) : 50 - 50
  • [9] Bevacizumab in glioblastoma multiforme
    Specenier, Pol
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (01) : 9 - 18
  • [10] Bevacizumab for the Treatment of Glioblastoma
    Gil-Gil, Miguel J.
    Mesia, Carlos
    Rey, Montserrat
    Bruna, Jordi
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 123 - 135
12345